Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:59 AM
Ignite Modification Date:
2025-12-24 @ 11:59 AM
NCT ID:
NCT04232761
Eligibility Criteria:
Inclusion Criteria:
* Histologically or cytologically confirmed castration-resistant adenocarcinoma of the prostate with bone metastases
* Treatment decision for Radium-223 according to local label needs to be made independent from and before patient enrollment in the study by the investigator
* No contra-indications according to the local marketing authorization
Exclusion Criteria:
* Previously treated with Radium-223 for any reason
* Currently treated in clinical trials including other Radium-223 studies or planned participation in an investigational program with interventions outside of routine clinical practice during the study period
Healthy Volunteers:
False
Sex:
MALE
Study:
NCT04232761
Study Brief:
Protocol Section:
NCT04232761